Cargando…
Clinicians’ attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza
BACKGROUND: The value of neuraminidase inhibitors (NAIs) in reducing severe clinical outcomes from influenza is debated. A clinical trial to generate better evidence is desirable. However, it is unknown whether UK clinicians would support a placebo-controlled trial. A survey was conducted to determi...
Autores principales: | Bradbury, Naomi, Nguyen-Van-Tam, Jonathan, Lim, Wei Shen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930775/ https://www.ncbi.nlm.nih.gov/pubmed/29716584 http://dx.doi.org/10.1186/s12913-018-3122-x |
Ejemplares similares
-
Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
por: Chong, Yong, et al.
Publicado: (2019) -
Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011) -
Systematic review of influenza resistance to the neuraminidase inhibitors
por: Thorlund, Kristian, et al.
Publicado: (2011) -
The role of neuraminidase inhibitors in the treatment and
prevention of influenza
por: Naem, Shahrour
Publicado: (2001) -
Exploring the chemical space of influenza neuraminidase inhibitors
por: Anuwongcharoen, Nuttapat, et al.
Publicado: (2016)